 |
 |
|
COMBINATION
PILLS
ORTHO TRI-CYCLEN®
LO Tablets (norgestimate/ethinyl
estradiol)
 ORTHO
TRI-CYCLEN LO gives you clinically proven effectiveness with
a low dose of hormones and a low rate of side effects. ORTHO
TRI-CYCLEN LO contains the same estrogen and progestin (ethinyl
estradiol and norgestimate) as the #1-prescribed birth control
pill. ORTHO TRI-CYCLEN LO is highly effective when taken
correctly and contains a unique combination of hormones -
25 micrograms (mcg) of estrogen and the trusted progestin,
norgestimate. The combination of norgestimate with a lower
level of the hormone estrogen (25 mcg) provides ORTHO TRI-CYCLEN
LO with highly effective contraception and cycle control.
In a clinical study, ORTHO TRI-CYCLEN LO demonstrated a lower
incidence of breakthrough bleeding and spotting compared to
a leading 20 mcg pill. ORTHO TRI-CYCLEN LO is indicated for
the prevention of pregnancy in women who elect to use oral
contraceptives as their method of contraception.
ORTHO
TRI-CYCLEN® Tablets
(norgestimate/ethinyl estradiol)
 ORTHO
TRI-CYCLEN is a highly effective birth control pill. In clinical
tests, ORTHO TRI-CYCLEN has been clinically proven to help
reduce mild to moderate acne—nearly 9 out of 10 women
saw improvements in their skin.
 ORTHO
TRI-CYCLEN can be a good choice for women 15 or over with
mild to moderate acne who have reached menstruation, are seeking
contraception, have no known contraindications to birth control
pills, and are unresponsive to topical acne medication.
ORTHO TRI-CYCLEN is more than 99% effective as birth control.
ORTHO-CYCLEN®
Tablets (norgestimate/ethinyl
estradiol)
 ORTHO-CYCLEN
is a contraceptive product containing 0.250 mg of the progestational
compound norgestimate and 0.035 mg of the estrogenic compound
ethinyl estradiol. ORTHO-CYCLEN was introduced in the United
States in 1992. It is indicated for the prevention of pregnancy
in women who elect to use oral contraceptives as a method
of contraception.
ORTHO-NOVUM MODICON®
Tablets (norethindrone/mestranol)
or (norethindrone/ ethinyl estradiol)
ORTHO-NOVUM
is a line of prescription oral contraceptive products available
as:
| |
 |
ORTHO-NOVUM 7/7/7 (0.5
mg norethindrone and 0.035 mg ethinyl estradiol), (0.75
mg norethindrone and 0.035 mg ethinyl estradiol), (1
mg norethindrone and 0.035 mg ethinyl estradiol)
|
| |
|
ORTHO-NOVUM 10/11 (0.5
mg norethindrone and 0.035 mg ethinyl estradiol), (1
mg norethindrone and 0.035 mg ethinyl estradiol)
|
| |
|
ORTHO-NOVUM
1/35 (1 mg norethindrone and 0.035 mg ethinyl estradiol)
|
| |
|
ORTHO-NOVUM 1/50 (1
mg norethindrone and 0.05 mg mestranol) |
Products in the ORTHO-NOVUM line are indicated for the prevention
of pregnancy in women who elect to use the Pill as a method
of contraception. ORTHO-NOVUM 1/50 was introduced in 1969;
ORTHO-NOVUM 1/35 in 1980; ORTHO-NOVUM 10/11 in 1982; and ORTHO-NOVUM
7/7/7 in 1984.
* ORTHO-NOVUM 1/50 contains higher doses of estrogen than
other oral contraceptives and should not be used unless specifically
recommended by your healthcare professional.
PROGESTIN-ONLY
PILLS
ORTHO MICRONOR®
Tablets (norethindrone)
 ORTHO MICRONOR
is a progestin-only birth control in the United
States and has been used successfully for over 20 years by
millions of women.
 ORTHO
MICRONOR can be used as early as 3 to 6 weeks after childbirth.
Women who are partially breast feeding (for example, supplementing
their breast milk with formula) can take ORTHO MICRONOR as
early as 3 weeks after childbirth. Women who are fully breast feeding
can take ORTHO MICRONOR as early as 6 weeks after delivery.
Studies
indicate that progestin-only oral contraceptives, such as
ORTHO MICRONOR, are over 99% effective in preventing pregnancy
when used consistently and correctly. The efficacy of ORTHO
MICRONOR in typical use is 95%.
|
What
You Should Know
ORTHO EVRA, ORTHO TRI-CYCLEN ORTHO TRI-CYCLEN LO,
ORTHO-CYCLEN, ORTHO MICRONOR, MODICON and ORTHO NOVUM® are hormonal contraceptives and are not for everybody. Serious as well
as minor side effects have been reported with the
use of hormonal contraceptives. Serious risks include
blood clots, stroke, heart attacks. Cigarette smoking
increases the risk of serious cardiovascular side
effects, especially in women over 35. Women who use
hormonal contraceptives are strongly advised not to
smoke. Hormonal contraceptives do not
protect against HIV or sexually transmitted diseases.
Hormones
from patches applied to the skin get into the blood
stream and are removed from the body differently than
hormones from birth control pills taken by mouth.
You will be exposed to about 60% more estrogen
if you use ORTHO EVRA than if you use a typical birth
control pill containing 35 micrograms (mcg) of estrogen.
In general, increased estrogen exposure may
increase the risk of serious side effects. The risk
of venous thromboembolic disease (blood clots in the
legs and/or the lungs) may be increased with ORTHO
EVRA compared with that of a birth control pill containing
norgestimate and 35 mcg of estrogen. One study found
a doubling of this risk and another study found no
increased risk.
ORTHO
MICRONOR is progestin-only. Women using these products
may be more likely to experience ovarian cysts or
an ectopic pregnancy.
For information on Warnings, Precautions, and additional
Adverse Reactions that may occur, regardless of drug
relationship, please see the appropriate package
insert:
Full
US Prescribing Information for ORTHO TRI-CYCLEN
Full
US Prescribing Information for ORTHO TRI-CYCLEN LO
Full
US Prescribing Information for ORTHO-CYCLEN
Full
US Prescribing Information for ORTHO-NOVUM / MODICON
products
Full
US Prescribing Information for ORTHO-NOVUM 1/50
Full
US Prescribing Information for ORTHO MICRONOR
|
|
|
|
|
|
